Galmed Pharmaceuticals (GLMD) EPS (Basic) Growth (5y) (2018 - 2025)
Galmed Pharmaceuticals (GLMD) EPS (Basic) Growth (5y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.61 Bn | 131.75 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.28 Bn | 60.09 Bn | 1.37 Bn |
| 4 | Moderna | 59.14 Bn | 54.00 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.13 Bn | 37.03 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.83 Bn | 28.52 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.07 Bn | 9.68 Bn | 668.28 Mn |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - |
| 10 | Galmed Pharmaceuticals | 2.28 Mn | -9.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 14.87% |
| Jun 30, 2024 | 14.87% |
| Jun 30, 2023 | 14.87% |
| Sep 30, 2022 | -15.08% |
| Jun 30, 2022 | -47.32% |
| Sep 30, 2021 | -53.24% |
| Mar 31, 2021 | -55.67% |
| Dec 31, 2020 | -132.85% |
| Sep 30, 2020 | 141.62% |
| Jun 30, 2020 | -25.94% |
| Mar 31, 2020 | -44.53% |
| Jun 30, 2019 | -14.89% |
| Mar 31, 2019 | -14.87% |
| Dec 31, 2018 | 15.47% |
| Jun 30, 2018 | -14.90% |
| Mar 31, 2018 | -54.75% |